Blog
There's Still Time to Reap This Lucrative Tax Break
In March, when the COVID-19 pandemic hit with full force, the IRS made the decision to postpone the tax-filing deadline from April 15 to July 15, giving Americans three more months to get their
AMD Is Poised to Gain Market Share in Race Against Intel
Advanced Micro Devices (NASDAQ: AMD) has been chipping away at Intel's (NASDAQ: INTC) market share in the central processing unit (CPU) space thanks to its Ryzen processors, and it looks like it
7 Top Stocks Under $7 to Buy in July
We're heading into the seventh month of the year, so let's roll with that traditionally lucky number. Let's explore seven low-priced investments that all happen to trade for $7 or less.
Naturally
Thinking of Waiting to Claim Your Social Security Benefits? Answer This Question First
As you get older, you have a lot of choices to make that will shape your retirement. One of the most important is when to start getting your Social Security checks. These benefits can be a key
Royal Caribbean Cruises in 4 Charts
One of the bigger battleground sectors in the COVID-19 era are travel stocks, particularly cruise stocks.
Cruising is one of the more cost-efficient ways to see the world, As the world economy
Here’s Why Activision Blizzard and Take-Two Are So Interested in Remakes of Old Games
As the video game industry prepares for a new generation of gaming consoles launching later this year, Activision Blizzard (NASDAQ: ATVI) and Take-Two Interactive (NASDAQ: TTWO) have been dipping
Amazon Can Benefit From Its Zoox Acquisition Better Than Anyone Else
Amazon (NASDAQ: AMZN) has announced it's agreed to acquire Zoox, a company building autonomous vehicles from the ground up with a robotaxi service in mind. While neither company disclosed terms of
Macy's Cuts Thousands More Jobs in the Hunt for Efficiency
The COVID-19 pandemic has disrupted business for lots of retailers. Few were harder hit than Macy's (NYSE: M), though. Sales fell about 45% in the first quarter of fiscal 2020. Moreover, its
The Surprising Reason the U.S. May Be Reluctant to Legalize Marijuana
Amid the chaos of 2020, which has included a stock market crash, the coronavirus disease 2019 (COVID-19) pandemic, and even some hoopla about the arrival of murder hornets, there's still the
4 Important Pieces of Investing Advice From Peter Lynch
There are plenty of well-known investors who are famous for their overwhelming success, but few have the track record Peter Lynch can boast of. In 1977, Lynch was put in charge of Fidelity's
2 Coronavirus-Proof Blue Chip Stocks To Watch
According to the National Bureau of Economic Research, the United States economy entered a recession in February, and many health experts fear that the coronavirus pandemic could resurge as the
3 Stocks to Buy and Hold for the Next 50 Years
I own about 45 different stocks in my portfolio, and I bought all of them with the intention of holding them forever. But, like any responsible investor, I occasionally sell stocks for a variety of
McCormick Looks More Attractive After Strong Q2 Results
McCormick (NYSE: MKC) is handling an unprecedented spike in demand right now. The global spice and flavorings giant announced fiscal second quarter earnings results this week that surpassed
Social Security Is Withholding Income From Seniors at the Worst Possible Time
It's not just younger Americans who are struggling financially during the COVID-19 crisis; older Americans are hurting as well. In fact, in April, the unemployment rate among workers aged 55 and
Meet the Stock That Turned $100 Into $2.7 Million
This year has represented quite the adventure for Wall Street and investors. While volatility never quite goes away when investing, we've had about a decade's worth of wild vacillations crammed into
Take $2,000 and Protect Your Portfolio With These 3 Stocks
2020 has reminded investors that the stock market is risky. After a more than decade-long bull market, the COVID-19 pandemic sent stocks plunging 30% in just a month, rattling investors who'd
3 Winning Stocks to Invest $2,500 Into Right Now
Over the past four months, investors have dealt with about a decade's worth of volatility -- and we're not even at the halfway mark of 2020 yet.
Uncertainty tied to the coronavirus disease 2019
Is It Too Late for New Subscription Video Services?
It seems like there's never been a better time to launch a new subscription streaming video service. Streaming hours have exploded this year as people spent more time at home, movie theaters closed
Is Hasbro's Dividend Helping or Hurting the Company?
Hasbro (NASDAQ: HAS), one of the world's largest toy and game manufacturers, has a long history of returning excess cash to shareholders. Although share repurchases were suspended in the first
7 ETFs That Could Help You Send Your Kids to College
College costs have been rising much faster than inflation over the past few decades. A study by LendingTree indicated that in-state public schools cost an average of $25,290 per year in the
Ditch These 3 Popular Oil ETFs and Consider Buying This 1 Instead
Oil prices have been extraordinarily volatile this year. Crude oil entered this year in the $60s before plummeting along with demand as governments restricted travel and nonessential businesses to
No 401(k)? Don't Use It as an Excuse to Neglect Your Retirement Savings
There are plenty of good reasons to save for retirement in a 401(k) plan. For one thing, many employers that sponsor 401(k)s also match employee contributions to varying degrees, which means you may
Is Spotify Stock a Buy?
Spotify (NYSE: SPOT) shares have been on an epic run since bottoming in March amid the market panic over COVID-19. The shares closed at just $118.18 on March 23 but now change hands at a whopping
Is Activision Blizzard Stock a Buy?
Summer is here, but with many households confined indoors due to COVID-19, video game stocks are doing well. In fact, while the S&P 500 remains down 6% year to date, all the largest U.S. video game
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
GW Pharmaceuticals (NASDAQ: GWPH) and Cara Therapeutics (NASDAQ: CARA) often get lumped together as cannabinoid-focused biotechs. However, that label is really only applicable to GW Pharmaceuticals


